Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of the American Society of Nephrology : JASN|February 9, 2023
ASH2L Controls Ureteric Bud Morphogenesis through the Regulation of RET/GFRA1 Signaling Activity in a Mouse ModelZiyi Zhao, Xuantong Dai, Gengru Jiang, et al.
Frontiers in Physiology|May 30, 2019
Survival Motor Neuron (SMN) Protein Insufficiency Exacerbates Renal Ischemia/Reperfusion InjuryXiaoqian Qian, Yichao Du, Gengru Jiang, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|July 23, 2018
Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from ChinaDan Zhang, Jun Zou, Chong Zhang, et al.
American Journal of Translational Research|May 21, 2019
MiR-424 is over-expressed and attenuates ischemia-reperfusion kidney injury via p53 and death receptor 6 pathwayShunjie Chen, Yao Yao, Fujun Lin, et al.
Orphanet Journal of Rare Diseases|June 20, 2022
Identification and functional characterization of the first deep intronic GLA mutation (IVS4+1326C>T) causing renal variant of Fabry diseaseXuantong Dai, Xue Zong, Xiaoxia Pan, et al.
BMC Nephrology|January 29, 2026
Deciphering the complexity: a case of kidney failure with co-inheritance of COL4A5 and APOE variantsXiaoyan Zhang, Shi Jin, Xuantong Dai, et al.
Frontiers in Pediatrics|December 1, 2022
A novel CLCN5 frame shift mutation responsible for Dent disease 1: Case reportJiajia Ni, Yaju Zhu, Fujun Lin, et al.
European Journal of Medical Genetics|October 29, 2017
THSD7A-associated membranous nephropathy in a patient with neurofibromatosis type 1Fujun Lin, Dan Zhang, Juan Chang, et al.
Renal Failure|May 13, 2025
Coenzyme Q10 supplementation in adult-onset focal segmental glomerulosclerosis caused by the Chinese common pathogenic variant c.737G > A (p.Ser246Asn) in the COQ8B geneShi Jin, Yiqin Shi, Pan Lin, et al.
RSC Advances|May 11, 2022
Micro RNA-155 inhibitor as a potential therapeutic strategy for the treatment of acute kidney injury (AKI): a nanomedicine perspectiveShunjie Chen, Jianping Shan, Wei Niu, et al.
Pageof 2